Advancing Efforts in Disease Interception
Release Date:
Ben Wiegand, global head of the World without Disease Accelerator at Janssen, the Pharmaceutical Companies of Johnson & Johnson, talks about efforts to prevent a disease or to identify it in its earliest stages for more effective treatments.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Advancing Efforts in Disease Interception